Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Pregnancy With Insomnia: a Trial of Acupuncture (GAS)

27 giugno 2017 aggiornato da: Assistance Publique - Hôpitaux de Paris

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Panoramica dello studio

Stato

Sconosciuto

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

  • To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
  • Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

  • Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
  • Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

  • Study Type: Multicentre, Interventional, randomized, 2 parallel groups
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Parallel Assignment
  • Masking: Single blind (patient blinded to intervention)
  • Primary Purpose: Treatment
  • One acupuncture session weekly for 4 consecutive weeks

Visits:

  • Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
  • Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
  • Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
  • End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Femmina

Descrizione

Inclusion Criteria:

  • Age > 18 years
  • Singleton pregnancy
  • Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
  • Insomnia Severity Index ≥ 10
  • Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
  • Patient understanding the study
  • Informed consent signed
  • Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

  • Threatened premature labor
  • Small fetus for gestational age
  • Pre-eclampsia
  • Insomnia starting before pregnancy
  • Use of psychotropic drugs before pregnancy
  • Use of recreational drugs during pregnancy
  • Known psychiatric disorder
  • Anticoagulant therapy
  • Patient reporting insomnia results from chronic or acute pain
  • Obstructive sleep apnea (OSA) requiring treatment
  • Patient under antidepressant therapy
  • Patient under legal guardianship or deprived of freedom

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Comparatore fittizio: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Insomnia severity index (ISI)
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pittsburgh Sleep Quality Index (PSQI)
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of any drug.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of alcohol
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of alcohol.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of tobacco
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of tobacco.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of cannabis
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of cannabis.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of other recreational substances or medicine
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Inclusion visit and 5 weeks after the first acupuncture session
Difference in the frequency of restless leg syndrome
Lasso di tempo: Inclusion visit and 5 weeks after the first acupuncture session

According to the guidelines of the International Restless Legs Syndrome Study Group.

The diagnosis of restless leg will rely on the presence of all of the following criteria:

  1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
  2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
  3. Symptoms are worse at rest with at least temporary relief by activity.
  4. Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Perinatal outcome - Gestational age at birth
Lasso di tempo: At birth
The gestational age at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth weight
Lasso di tempo: At birth
The weight (in gr) at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth height
Lasso di tempo: At birth
The height (in cm) at birth of the newborn will be recorded.
At birth
Perinatal outcome - sex
Lasso di tempo: At birth
The sex of the newborn will be recorded.
At birth
Perinatal outcome - perinatal mortality
Lasso di tempo: At birth
The perinatal mortality will be recorded.
At birth
Perinatal outcome - five minutes Apgar score
Lasso di tempo: At birth
The five minutes Apgar score will be recorded.
At birth
Perinatal outcome - cesarean section rate
Lasso di tempo: At birth.
Cesarean section rate will be recorded.
At birth.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Anticipato)

1 settembre 2017

Completamento primario (Anticipato)

1 gennaio 2019

Completamento dello studio (Anticipato)

1 maggio 2019

Date di iscrizione allo studio

Primo inviato

23 maggio 2017

Primo inviato che soddisfa i criteri di controllo qualità

19 giugno 2017

Primo Inserito (Effettivo)

21 giugno 2017

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

28 giugno 2017

Ultimo aggiornamento inviato che soddisfa i criteri QC

27 giugno 2017

Ultimo verificato

1 aprile 2017

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

No

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

prodotto fabbricato ed esportato dagli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Acupuncture needles

3
Sottoscrivi